2022
DOI: 10.1101/2022.01.21.477251
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A Cyclisation and Docking Protocol for Cyclic Peptide-Protein Modelling using HADDOCK2.4

Abstract: An emerging class of therapeutic molecules are cyclic peptides with over 40 cyclic peptide drugs currently in clinical use. Their mode of action is, however, not fully understood, impeding rational drug design. Computational techniques could positively impact their design but modeling them and their interactions remains challenging due to their cyclic nature and their flexibility. This study presents a step-by-step protocol for generating cyclic peptide conformations and docking them to their protein target us… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 37 publications
(37 reference statements)
0
1
0
Order By: Relevance
“…Thus, dynamic binding effects of unbound (apo) protein states, where the conformational architecture of the binding site is significantly different from holo complexes, cannot be modeled in that way. Only recently, molecular docking studies of peptidic MCs were performed in apo structures using specialized tools for (cyclic) peptides, , emphasizing the current need for methods capable of handling these structural challenges.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, dynamic binding effects of unbound (apo) protein states, where the conformational architecture of the binding site is significantly different from holo complexes, cannot be modeled in that way. Only recently, molecular docking studies of peptidic MCs were performed in apo structures using specialized tools for (cyclic) peptides, , emphasizing the current need for methods capable of handling these structural challenges.…”
Section: Introductionmentioning
confidence: 99%